Abiraterone in Prostate Cancer Full Text
Clinical Cancer Research,  Clinical Article

Stein MN et al. – Abiraterone's efficacy shows the importance of androgen signaling in patients with castrate–resistant metastatic disease, with additional confirmation from recent studies of other novel agents such as MDV3100, an androgen receptor signaling inhibitor.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore